Results from the Multicentre Randomized Arterial Revascularization Therapy Study
V. Legrand1 MD, PhD, FESC,
P. Serruys2 MD, PhD, FACC, FESC,
WK Lindeboom3 PhD,
M. Vrolix4 MD,
G. Fransen4 MD,
P. Materne5 MD,
G. Dekoster5 MD,
R. Seabra-Gomes6 MD,FESC,
J. Queiroz E Melo6 MD
1CHU Liege Belgium.
2Thoraxcenter, Rotterdam, The Netherlands.
3Cardialysis, Rotterdam, The Netherlands.
4St Jansziekenhuis, Genk, Belgium.
5CHR Citadelle, Liege, Belgium.
6Hosp Santa Cruz, Carnaxide, Portugal.
Key words : coronary angioplasty, stent, coronary bypass surgery, elderly.
Introduction
As the population ages, an increasing number of elderly patients are presenting with symptomatic multivessel coronary artery disease requiring revascularization. However, the most appropriate myocardial revascularization procedure for older patients with multivessel disease is still controversial. Indeed, it is well recognized that the procedure-related morbidity associated with either percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) increases dramatically with age.
